Publicacions

Metabolisme i Càncer

Lupu R, Menendez JA

Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?

Endocrinology, 2006, 147, 4056-4066 dx.doi.org/10.1210/en.2006-0486

Genètica Cardiovascular

Scornik FS, Desai M, Brugada R, Guerchicoff A, Pollevick GD, Antzelevitch C, Pérez GJ

Functional expression of "cardiac-type" Nav1.5 sodium channel in canine intracardiac ganglia.

Heart Rhythm, 2006, 3, 842-850 dx.doi.org/10.1016/j.hrthm.2006.03.021

Patologia Cerebrovascular

Serena J, Rodríguez-Yáñez M, Castellanos M

Deterioration in acute ischemic stroke as the target for neuroprotection.

CEREBROVASCULAR DISEASES, 2006, 21 Suppl 2, 80-88 dx.doi.org/10.1159/000091707

Nutrició, Eumetabolisme i Salut , Endocrinologia pediàtrica

Esteve E, Villuendas G, Mallolas J, Vendrell J, López-Bermejo A, Rodríguez M, Recasens M, Ricart W, San Millán JL, Escobar-Morreale H, Richart C, Fernández-Real JM

Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome.

CLINICAL ENDOCRINOLOGY, 2006, 65, 88-91 dx.doi.org/10.1111/j.1365-2265.2006.02553.x

Metabolisme i Càncer

Menendez JA, Mehmi I, Lupu R

Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression.

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24, 3735-3746 dx.doi.org/10.1200/JCO.2005.04.3489

Neurodegeneració i Neuroinflamació

López-Pousa S, Garre Olmo J, Vilalta Franch J, Turon Estrada A, Soler Cors O, Pericot Nierga I

Factores asociados a la mortalidad en pacientes con enfermedad de Alzheimer tratados con galantamina.

MEDICINA CLINICA, 2006, 127, 206-210 dx.doi.org/10.1157/13091012

Nutrició, Eumetabolisme i Salut

Fernández-Real JM, Recasens M, Ricart W

Octreotide-induced manic episodes in a patient with acromegaly.

ANNALS OF INTERNAL MEDICINE, 2006, 144, 704-704 dx.doi.org/10.7326/0003-4819-144-9-200605020-00026

Nutrició, Eumetabolisme i Salut

Fernández-Real JM, Botas-Cervero P, Lainez B, Ricart W, Delgado E

An alternatively spliced soluble TNF-alpha receptor is associated with metabolic disorders - A replication study

CLINICAL IMMUNOLOGY, 2006, 121, 236-241 dx.doi.org/10.1016/j.clim.2006.07.011

Genètica Cardiovascular

Maury P, Hollington L, Duparc A, Brugada R

Short QT syndrome: Should we push the frontier forward?

Heart Rhythm, 2005, 2, 1135-1137 dx.doi.org/10.1016/j.hrthm.2005.06.023

Nutrició, Eumetabolisme i Salut

Esteve E, Ricart W, Fernández-Real JM

Dyslipidemia and inflammation: an evotutionary conserved mechanism

CLINICAL NUTRITION, 2005, 24, 16-31 dx.doi.org/10.1016/j.clnu.2004.08.004

Nutrició, Eumetabolisme i Salut

Puga I, Lainez B, Fernández-Real JM, Buxadé M, Broch M, Vendrell J, Espel E

A polymorphism in the 3 ` untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression

Endocrinology, 2005, 146, 2210-2220 dx.doi.org/10.1210/en.2004-1366

Metabolisme i Càncer

Menendez JA, Colomer R, Lupu R

Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?

MEDICAL HYPOTHESES, 2005, 64, 342-349 dx.doi.org/10.1016/j.mehy.2004.07.022

Genètica Cardiovascular

Brugada P, Brugada R, Brugada J

Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing?

Circulation, 2005, 112, 279-292 dx.doi.org/10.1161/CIRCULATIONAHA.104.485326

Metabolisme i Càncer

Vellon L, Menendez JA, Lupu R

AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.

Oncogene, 2005, 24, 3759-3773 dx.doi.org/10.1038/sj.onc.1208452

Metabolisme i Càncer

Menendez JA, Vellon L, Colomer R, Lupu R

Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97, 1611-1615 dx.doi.org/10.1093/jnci/dji343

Metabolisme i Càncer

Menendez JA, Colomer R, Lupu R

Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.

MEDICAL HYPOTHESES, 2005, 64, 337-341 dx.doi.org/10.1016/j.mehy.2004.06.032

Genètica Cardiovascular

Brugada R

Is atrial fibrillation a genetic disease?

JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2005, 16, 553-556 dx.doi.org/10.1111/j.1540-8167.2005.40703.x

Metabolisme i Càncer

Menendez JA, Vellon L, Mehmi I, Teng PK, Griggs DW, Lupu R

A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.

Oncogene, 2005, 24, 761-779 dx.doi.org/10.1038/sj.onc.1208238

Metabolisme i Càncer

Menendez JA, Lupu R, Colomer R

Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer.

DRUG NEWS & PERSPECTIVES, 2005, 18, 375-385 dx.doi.org/10.1358/dnp.2005.18.6.927929

Metabolisme i Càncer

Menendez JA, Lupu R

RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2005, 15, 33-40

Targeting fatty acid synthase in breast and endometrial cancer: An alternative to selective estrogen receptor modulators?

Functional expression of "cardiac-type" Nav1.5 sodium channel in canine intracardiac ganglia.

Deterioration in acute ischemic stroke as the target for neuroprotection.

Polymorphisms in the interleukin-6 receptor gene are associated with body mass index and with characteristics of the metabolic syndrome.

Trastuzumab in combination with heregulin-activated Her-2 (erbB-2) triggers a receptor-enhanced chemosensitivity effect in the absence of Her-2 overexpression.

Factores asociados a la mortalidad en pacientes con enfermedad de Alzheimer tratados con galantamina.

Octreotide-induced manic episodes in a patient with acromegaly.

An alternatively spliced soluble TNF-alpha receptor is associated with metabolic disorders - A replication study

Short QT syndrome: Should we push the frontier forward?

Dyslipidemia and inflammation: an evotutionary conserved mechanism

A polymorphism in the 3 ` untranslated region of the gene for tumor necrosis factor receptor 2 modulates reporter gene expression

Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids?

Should patients with an asymptomatic Brugada electrocardiogram undergo pharmacological and electrophysiological testing?

AlphaVbeta3 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer.

Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene.

Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.

Is atrial fibrillation a genetic disease?

A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway.

Targeting fatty acid synthase: potential for therapeutic intervention in her-2/neu-overexpressing breast cancer.

RNA interference-mediated silencing of the p53 tumor-suppressor protein drastically increases apoptosis after inhibition of endogenous fatty acid metabolism in breast cancer cells.

Coneix l’IDIBGI!